Cords, channels, corridors and conduits: Critical architectural elements facilitating cell interactions in the lymph node cortex

被引:325
作者
Gretz, JE
Anderson, AO
Shaw, S
机构
[1] NCI,EXPT IMMUNOL BRANCH,HUMAN IMMUNOL SECT,NIH,BETHESDA,MD 20892
[2] USA,MED RES INST INFECT DIS,DEPT CLIN PATHOL,DIAGNOST SYST DIV,FT DETRICK,MD 21702
关键词
D O I
10.1111/j.1600-065X.1997.tb00955.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The lymph node cortex is a critical site for encounter between recirculating T cells and their specific antigens. Due to its extreme plasticity, Little is understood of the underlying functional unit of the lymph node cortex, the paracortical cord. The idealized paracortical cord (approximately 100 mu m by 1000 mu m) stretches from a medullary cord to the base of a B-cell follicle. In cross-section, a cord can be visualized as a set of nested cylinders consisting of spaces bounded by cells. The spaces are: i) the lumen of the high endothelial venule (HEV), ii) perivenular channels - narrow potential spaces (0.1 mu m) rightly encircling the HEV, iii) corridors - broad spaces (10-15 mu m) constituting the majority of the parenchyma, and iv) the cortical sinus. In addition to these spaces for cell traffic, the conduit (fifth space) is a special delivery system for the transit of soluble factors to the HEV and emigrating lymphocytes. The cellular barriers between these spaces are high endothelium, fibroblastic reticular cells, or sinus-lining cells. This review describes the spaces of the paracortical cord and their cellular boundaries, outlines the movement of cells and fluids through these spaces, and discusses how this anatomy affects the efficiency of surveillance by T cells.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 79 条
[1]
Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation [J].
Abe, Y ;
Sugisaki, K ;
Dannenberg, AM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (06) :692-703
[2]
Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031
[3]
ANDERSON AO, 1976, IMMUNOLOGY, V31, P731
[4]
ANDERSON AO, 1975, AM J PATHOL, V80, P387
[5]
ANDERSON AO, 1985, INT J IMMUNOTHER, V1, P185
[6]
ANDERSON AO, 1982, ANIMAL MODELS IMMUNO, P25
[7]
ANDERSON AO, 1995, CLIN IMMUNOLOGY, P39
[8]
ANDERSON ND, 1976, IMMUNOLOGY, V31, P455
[9]
ANDERSON ND, 1975, AM J PATHOL, V81, P131
[10]
ANDERSON ND, 1975, FED PROC, V34, P842